Friday, February 27, 2009

Seroquel Becomes Zyprexa, Part 2. But With More Sex.

›
I had a big post on Abilify ready to go for today, but I'll sit on it for a few days because Seroquel is the new Zyprexa, and that is th...
2 comments:
Friday, February 13, 2009

What's Next for Schatzberg?

›
An advertisement in the Psychiatric Times ( page 34 of .pdf) calls for applicants for the Chair of the Department of Psychiatry and Behavi...
2 comments:
Tuesday, January 27, 2009

Abilify For Depression: I'm Not the Only Skeptic

›
In April 2008, findings were published in the Journal of Clinical Psychopharmacology which claimed that the atypical antipsychotic aripipra...
9 comments:
Friday, January 16, 2009

Zyprexa: Lilly Admits Guilt, But Also Blame Physicians

›
In February 2007, I wrote a post in which I described evidence that Lilly's antipsychotic olanzapine (Zyprexa) was marketed off-label f...
6 comments:
Monday, January 12, 2009

The Budget Crisis, Universities, and Key Opinion Leaders

›
Everyone knows that state budgets across the United States are in a crunch. All state-supported universities are looking for sources of inc...
Wednesday, January 07, 2009

Sowing the Seeds of Lexapro

›
I'm reading an article with my jaw completely agape and I thought I'd share the pain. The good people at Forest Pharmaceuticals have...
16 comments:
Monday, January 05, 2009

We're All Mentally Disordered: College-Age Edition

›
A study in the December 2008 issue of the Archives of General Psychiatry concluded that almost half of college aged Americans suffered from...
4 comments:
Friday, January 02, 2009

KOL Continues to Vanish

›
Charles Nemeroff, about whom I have written much , continues to disappear. His latest vanishing act: From a psychiatric research gathering ...
2 comments:
Wednesday, December 17, 2008

The Incredible Vanishing Key Opinion Leader

›
Charles Nemeroff, former chair of psychiatry at Emory University and key opinion leader extraordinaire has vanished. Not quite vanished fro...
7 comments:
Wednesday, December 10, 2008

Treatment Guidelines and GSK's Open Disclosure

›
Last week, I noted that a recently published article had found that studies favoring GSK's "mood stabilizer" Lamictal tended...
Thursday, December 04, 2008

Lamictal: Break Out the Shovel

›
GlaxoSmithKline, manufacturer of lamotrigine (Lamictal), the antiepileptic drug used widely for bipolar disorder, happily hid clinical tr...
19 comments:
Tuesday, November 25, 2008

Key Opinion Leader With A Very Short Fuse

›
Psychiatrist Joe "Short Fuse" Biederman of Harvard University is really in hot water now. The sordid details can be seen in a fan...
6 comments:
Thursday, November 20, 2008

Staying Alive

›
The day job has been merciless lately and promises little relief in the near future. Thanks for the emails. I am surviving and hope to wri...
1 comment:
Friday, October 31, 2008

You Really Can Report Safety Data

›
A new study concluded that the combination of sertraline (Zoloft) and cognitive-behavioral therapy (CBT) worked better than either treatment...
8 comments:
Monday, October 27, 2008

Psychiatric Diagnoses: Fact or Fiction?

›
Below is a guest post from Tim Desmond. I do not necessarily agree with all of the the contents of the post below, but I thought the topic w...
14 comments:
Saturday, October 18, 2008

The Latest on Kiddie Bipolar

›
A recent study in the Archives of General Psychiatry claimed that kiddie bipolar tends to become adult bipolar. I have read the study and ...
8 comments:
Friday, October 10, 2008

APA Membership Rejects Torture

›
APA Membership Rejects Torture The American Psychological Association membership recently overrode their leadership (the Council of Represen...
2 comments:
Monday, October 06, 2008

A Month in The Life of Chuck "High Life" Nemeroff

›
The psychiatry world is belatedly exhibiting outrage toward a man whose ability to lure pharma cash seems to know no bounds. He may be the ...
8 comments:
Friday, October 03, 2008

Uh-Oh Chuck, They Out To Get You, Man

›
According to the New York Times and Wall Street Journal , it looks like Charlie " Bling Bling " Nemeroff is under investigation b...
1 comment:
Wednesday, October 01, 2008

Prialt Pushed Through Duplicate Publication

›
Apparently, the same data on Elan's pain medication Prialt (ziconotide) was published twice. Same data set. No reference in the second...